Terms: = Lung cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Diagnosis
1510 results:
1. Gold Nanoprobes for Detection of a Crucial egfr Deletion for Early diagnosis of Non-Small-Cell lung cancer.
Enea M; Nuekaew A; Franco R; Pereira E
Biosensors (Basel); 2024 Mar; 14(4):. PubMed ID: 38667155
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.
Sun Y; Qin S; Wang S; Pang J; Ou Q; Liang W; Zhong H
J Pathol Clin Res; 2024 May; 10(3):e12375. PubMed ID: 38661052
[TBL] [Abstract] [Full Text] [Related]
3. Precision nanomedicine to treat non-small cell lung cancer.
Dessai A; Nayak UY; Nayak Y
Life Sci; 2024 Jun; 346():122614. PubMed ID: 38604287
[TBL] [Abstract] [Full Text] [Related]
4. [First-line Treatment with Furmonertinib Mesylate in lung Adenocarcinoma Patient
with egfr Exon 20 Insertion Mutantion].
Li Z; Wei T; Zeng D; Zhao L; Zhang J; Chen L
Zhongguo Fei Ai Za Zhi; 2024 Mar; 27(3):241-244. PubMed ID: 38590198
[TBL] [Abstract] [Full Text] [Related]
5. Comparison between next-generation sequencing and multiplex polymerase chain reaction assays for nonsmall-cell lung cancer molecular diagnosis.
Murakami S; Shinada K; Otsutsumi Y; Komine F; Yuan Y; Nakamura J; Katakura S; Kondo T; Kato T; Yokose T; Saito H
Cancer Med; 2024 Apr; 13(7):e7162. PubMed ID: 38572952
[TBL] [Abstract] [Full Text] [Related]
6. Molecular and functional insight into anti-egfr nanobody: Theranostic implications for malignancies.
Tripathy RK; Pande AH
Life Sci; 2024 May; 345():122593. PubMed ID: 38554946
[TBL] [Abstract] [Full Text] [Related]
7. Distinguishing egfr mutation molecular subtypes based on MRI radiomics features of lung adenocarcinoma brain metastases.
Xu J; Yang Y; Gao Z; Song T; Ma Y; Yu X; Shi C
Clin Neurol Neurosurg; 2024 May; 240():108258. PubMed ID: 38552362
[TBL] [Abstract] [Full Text] [Related]
8. Assessing egfr-mutated NSCLC with bone metastasis: Clinical features and optimal treatment strategy.
Chen WC; Cheng WC; Chen CL; Liao WC; Chen CH; Chen HJ; Tu CY; Lin CC; Hsia TC
Cancer Med; 2024 Apr; 13(7):e7152. PubMed ID: 38549499
[TBL] [Abstract] [Full Text] [Related]
9. Genomic testing and targeted therapy of non-small cell lung cancer in China: a nationwide survey of physicians and clinical pathologists.
Wang J; Ying J; Wang Z; Meng X; Wu M; Qian C
Ann Palliat Med; 2024 Mar; 13(2):221-229. PubMed ID: 38509647
[TBL] [Abstract] [Full Text] [Related]
10. Clinical Management of Patients with Non-Small Cell lung cancer, Brain Metastases, and Actionable Genomic Alterations: A Systematic Literature Review.
Khasraw M; Yalamanchili P; Santhanagopal A; Wu C; Salas M; Meng J; Karnoub M; Esker S; Felip E
Adv Ther; 2024 May; 41(5):1815-1842. PubMed ID: 38509433
[TBL] [Abstract] [Full Text] [Related]
11. Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non-Small Cell lung cancer: A Multiregional Chart Review in the United States, Europe, and Japan.
Leal TA; Dasgupta A; Latremouille-Viau D; Rossi C; Rai P; Barlesi F; Liu SV
JCO Glob Oncol; 2024 Mar; 10():e2300483. PubMed ID: 38484195
[TBL] [Abstract] [Full Text] [Related]
12. Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib.
Ge W; Wang Y; Quan M; Mao T; Bischof EY; Xu H; Zhang X; Li S; Yue M; Ma J; Yang H; Wang L; Yu Z; Wang L; Cui J
Mol Cancer; 2024 Mar; 23(1):48. PubMed ID: 38459558
[TBL] [Abstract] [Full Text] [Related]
13. Severe megaloblastic anemia in a patient with advanced lung adenocarcinoma during treatment with erlotinib: a case report and literature review.
Yan X; Kong J; Wang J; Wang C; Shen H
BMC Pulm Med; 2024 Mar; 24(1):121. PubMed ID: 38448889
[TBL] [Abstract] [Full Text] [Related]
14. Label-free fluorescent sensor for sensitive detection of ctDNA based on water stabilized CsPbBr
Yang X; Zhao L; Yang S; Tang M; Fa H; Huo D; Hou C; Yang M
Biosens Bioelectron; 2024 Jun; 253():116165. PubMed ID: 38437747
[TBL] [Abstract] [Full Text] [Related]
15. Describing differences among populations of thoracic tumors patients under and over 80 years: Data analysis from the SLCG thoracic tumor registry.
Provencio M; Cobo M; Rodriguez-Abreu D; Carcereny E; Cantero A; Calvo V; López Castro R; Bernabé R; Bosch-Barrera J; Massutí B; García Campelo R; Sánchez-Hernández A; Laura Ortega A; Guirado M; Del Barco E; Camps C; Casal-Rubio J; Dómine M; Angeles Sala M; Padilla A; Luís González Larriba J; de Asís Aparisi F;
Lung Cancer; 2024 Apr; 190():107513. PubMed ID: 38432027
[TBL] [Abstract] [Full Text] [Related]
16. Next-Generation Sequencing in lung cancers-A Single-Center Experience in Taiwan.
Lai WA; Huang YS; Chang KC; Yang SF; Yang CJ; Liu YW; Chen HD
Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399524
[No Abstract] [Full Text] [Related]
17. Correlation of MRI quantitative perfusion parameters with egfr, VEGF and egfr gene mutations in non-small cell cancer.
Zou M; Zhang B; Shi L; Mao H; Huang Y; Zhao Z
Sci Rep; 2024 Feb; 14(1):4447. PubMed ID: 38396128
[TBL] [Abstract] [Full Text] [Related]
18. Signaling Pathways of AXL Receptor Tyrosine Kinase Contribute to the Pathogenetic Mechanisms of Glioblastoma.
Repici A; Ardizzone A; De Luca F; Colarossi L; Prestifilippo A; Pizzino G; Paterniti I; Esposito E; Capra AP
Cells; 2024 Feb; 13(4):. PubMed ID: 38391974
[TBL] [Abstract] [Full Text] [Related]
19. Adenovirus pneumonia mimicking osimertinib-induced pneumonitis in a patient with advanced NSCLC with egfr mutation: A case report.
Imai T; Yoshida T; Ohe Y
Thorac Cancer; 2024 Mar; 15(9):749-751. PubMed ID: 38379439
[TBL] [Abstract] [Full Text] [Related]
20. The emerging perioperative treatment paradigm for non-small cell lung cancer: a narrative review.
Christopoulos P
Chin Clin Oncol; 2024 Feb; 13(1):12. PubMed ID: 38372058
[TBL] [Abstract] [Full Text] [Related]
[Next]